Top Section/Ad
Top Section/Ad
Most recent
Regulators nervous about the perils of private credit should reflect on their own role restraining bank lending while pushing insurers into private markets
The Fairbridge 2025-1 transaction is a huge leap in the right direction for bringing the asset class to the public RMBS market
As thrilling as last week's Reverse Yankee-led corporate bond fest in Europe may have been, it did not confirm the market has matured to its magnificent final form
Greater competition may already be paying dividends
More articles/Ad
More articles/Ad
More articles
-
Hong Kong has had its first taste of a pre-revenue biotechnology stock with the listing by Ascletis Pharma. Unfortunately, the company got caught up in a wave of volatility and the shares have not fared well. It was not a good start for biotech but the sector should not be judged by this one deal, as it was just the first from a bulging IPO pipeline. -
Bond index providers are racing to include Chinese bonds in their benchmarks. But before taking the leap, they should study a recent decision on A-share inclusion — and the sceptical response it got from investors.
-
Eskom’s return to markets this week is the latest example of how the best bet in the emerging markets is often not on how strong a company is, but how strong its friends are. That is a lesson well remembered for investors, as EM hits a rocky patch.
-
The UK government is completely mishandling Brexit and its abandonment of financial services in negotiations has cast a cloud over the City. The government must now fix the situation via the most pragmatic Brexit possible — a bid to remain in the European Economic Area (EEA).
-
There was a time, not so very long ago, that Barclays and Deutsche Bank seemed to be plunging down the same path together. Fixed income flow monsters both, the two firms unveiled superficially similar revamps in 2014 and 2015, driven by the same structural imperatives. In the last year though, the pair couldn’t have been more different.
-
When China Tower launched its Hong Kong IPO last week, it abandoned a long tradition of state-owned enterprises relying on cornerstone tranches for a major chunk of distribution. It was a bold move. Later this week, we will know whether it was a smart one.
